Penumbra, Inc. (PEN) Indigo Aspiration System IDE Trial for Acute Pulmonary Embolism Meets Primary Safety and Efficacy Endpoints

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. GOOGL
6. APGE
7. HOOD
8. DFTX
9. MU
10. IBM

Go back to Penumbra, Inc. (PEN) Indigo Aspiration System IDE Trial for Acute Pulmonary Embolism Meets Primary Safety and Efficacy Endpoints

Penumbra, Inc. (PEN) Tops Q3 EPS by 9c, Revenues Beat

November 7, 2019 4:51 PM EST

Penumbra, Inc. (NYSE: PEN) reported Q3 EPS of $0.25, $0.09 better than the analyst estimate of $0.16. Revenue for the quarter came in at $139.5 million versus the consensus estimate of $133.97 million.

For earnings history and earnings-related data on Penumbra, Inc. (PEN) click here.

... More